Side Effects of Methylprednisolone Tablets

Methylprednisolone tablets are used for anti-inflammatory treatment, including rheumatic diseases, dermatological conditions, allergic states, and ocular disorders. They are also indicated in organ transplantation, oncology, shock management, and for preventing nausea, vomiting, and endocrine disturbances associated with cancer chemotherapy. So, what are the side effects of methylprednisolone tablets? The following section addresses this question.

Side Effects of Methylprednisolone Tablets

1. Muscle Weakness

Myopathy is associated with disruption of protein synthesis—critical for muscle repair and maintenance. The degree of muscle weakness and atrophy correlates with both the dose and duration of methylprednisolone therapy: higher doses and longer treatment periods increase the risk and severity of muscle loss.

2. Osteoporosis

Osteoporosis and bone loss represent the most common side effects of methylprednisolone tablets. These may result from multiple mechanisms, including suppression of bone-forming cells (osteoblasts), reduced intestinal calcium absorption, and increased urinary calcium excretion. Baseline bone density scanning is typically recommended prior to initiating methylprednisolone therapy.

3. Ocular Abnormalities

Ocular complications such as glaucoma, cataracts, and exophthalmos may occur. These adverse effects are most frequently observed in patients with a family history of such conditions. A comprehensive ophthalmic examination is therefore essential before starting methylprednisolone therapy; if pre-existing ocular disease is identified, treatment should be discontinued to prevent further damage.

Knowledge Extension: Therapeutic Effects and Indications of Methylprednisolone Tablets

1. Treatment of Multiple Disorders

Methylprednisolone tablets are indicated for conditions such as anterior pituitary insufficiency, adrenal cortical insufficiency, and autoimmune diseases. Systemic corticosteroid therapy—including methylprednisolone—is appropriate for nearly all diffuse connective tissue diseases, including systemic lupus erythematosus, polymyositis, dermatomyositis, various vasculitides, and mixed connective tissue disease. However, methylprednisolone must always be used strictly under medical supervision.

2. Management of Infectious Diseases

Methylprednisolone tablets may be employed in severe infections such as sepsis and meningitis, as well as in various forms of shock—including anaphylactic, toxic, cardiogenic, and hypovolemic shock. Additionally, they are effective in treating certain allergic disorders, such as drug allergies and contact dermatitis.

The above outlines the major side effects associated with methylprednisolone tablets. We hope this information proves helpful to you.